Literature DB >> 34021048

Influenza Virus and SARS-CoV-2 Vaccines.

Adam M Sandor1,2,3,4, Michael S Sturdivant1,5, Jenny P Y Ting6,2,3.   

Abstract

Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34021048      PMCID： PMC8722349          DOI： 10.4049/jimmunol.2001287

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.426


  233 in total

1.  Developing Covid-19 Vaccines at Pandemic Speed.

Authors:  Nicole Lurie; Melanie Saville; Richard Hatchett; Jane Halton
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

2.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

Review 3.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

5.  Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.

Authors:  Jeffrey C Kwong; Priya P Vasa; Michael A Campitelli; Steven Hawken; Kumanan Wilson; Laura C Rosella; Therese A Stukel; Natasha S Crowcroft; Allison J McGeer; Lorne Zinman; Shelley L Deeks
Journal:  Lancet Infect Dis       Date:  2013-06-28       Impact factor: 25.071

6.  A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.

Authors:  Ying Wu; MyungSam Cho; David Shore; Manki Song; JungAh Choi; Tao Jiang; Yong-Qiang Deng; Melissa Bourgeois; Lynn Almli; Hua Yang; Li-Mei Chen; Yi Shi; Jianxu Qi; An Li; Kye Sook Yi; MinSeok Chang; Jin Soo Bae; HyunJoo Lee; JiYoung Shin; James Stevens; SeoungSuh Hong; Cheng-Feng Qin; George F Gao; Shin Jae Chang; Ruben O Donis
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

Review 7.  T cell-mediated immune response to respiratory coronaviruses.

Authors:  Rudragouda Channappanavar; Jincun Zhao; Stanley Perlman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

9.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

10.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321
View more
  3 in total

Review 1.  Strategies for fighting pandemic virus infections: Integration of virology and drug delivery.

Authors:  Takashi Nakamura; Norikazu Isoda; Yoshihiro Sakoda; Hideyoshi Harashima
Journal:  J Control Release       Date:  2022-02-03       Impact factor: 11.467

2.  Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19.

Authors:  Shaun D Black
Journal:  Cureus       Date:  2022-01-06

3.  Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.

Authors:  Ramireddy Bommireddy; Shannon Stone; Noopur Bhatnagar; Pratima Kumari; Luis E Munoz; Judy Oh; Ki-Hye Kim; Jameson T L Berry; Kristen M Jacobsen; Lahcen Jaafar; Swe-Htet Naing; Allison N Blackerby; Tori Van der Gaag; Chloe N Wright; Lilin Lai; Christopher D Pack; Sampath Ramachandiran; Mehul S Suthar; Sang-Moo Kang; Mukesh Kumar; Shaker J C Reddy; Periasamy Selvaraj
Journal:  Vaccines (Basel)       Date:  2022-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.